Gastric intestinal metaplasia is a common complication for H. pylori-induced metaplasia-dysplasia-carcinoma sequence, which was characterized by increased CDX2 and/or MUC2 expression, which has been received PPI treatment. This evidence concerns the gene MUC2 and dysplasia.